Samsung invests in Flagship Pioneering Fund VIII
Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis and Samsung Venture Investment Corporation (collectively hereinafter referred to as “Samsung”) announced today an investment into Flagship Pioneering Fund VIII (“Fund VIII”) to help fuel breakthrough innovations in human health and sustainability. In addition to the strategic partnership that Flagship Pioneering (hereinafter referred to as “Flagship”) and Samsung …
Samsung invests in Flagship Pioneering Fund VIII Read More »